trending Market Intelligence /marketintelligence/en/news-insights/trending/4B-VOSjtdJcKrO5ZZ6eWdA2 content esgSubNav
In This List

Allena Pharmaceuticals plans $92M IPO

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Allena Pharmaceuticals plans $92M IPO

Allena Pharmaceuticals Inc. plans to raise $92 million through an initial public offering of common stock.

The Newton, Mass.-based biotech company granted underwriters a 30-day option to buy additional common shares at the offering price.

According to its prospectus, Allena Pharmaceuticals applied to list the shares on the Nasdaq Global Market under the symbol ALNA.

Credit Suisse Securities (USA) LLC, Jefferies LLC, Cowen and Co. LLC and Wedbush Securities Inc. are acting as underwriters for the offering.